Breast Implant Illness Exposed: Plastic Surgeon Reveals Horrifying Reality

Brier says that most patients getting implants today are not warned about BII. When symptoms arise years later, they don’t think to link them to the implants, and their general physicians also do not make the connection. He and his team are pushing for BII to become a standard part of implant consent. He clarifies that the goal is not to ban implants but to ensure truly informed choice. He recounts that he used to place implants without any mention of BII because the teaching was that implants are inert; now, he no longer performs primary augmentation but sees great value in volume enhancement via fat transfer or lift without implants.

Brier notes that there is still controversy in plastic surgery about whether total capsulectomy is necessary. Some surgeons only remove the implant or do a partial capsulectomy. However, he cites his own experience with referrals of patients who had implants removed elsewhere without full capsulectomy and returned with persistent symptoms that resolved only after a second surgery with total capsule removal. He also warns that leaving the capsule behind may hide rare cancers like ALCL or squamous cell carcinoma, which the FDA has flagged. The en bloc technique, borrowed from oncologic surgery, ensures the implant and its capsule are removed as a single specimen without contamination of the surgical field, and then sent for pathology. This protocol, while more demanding, is his standard for BII patients.

Brier emphasizes that taking out the implants is not the entire solution. He compares it to mold exposure: you must leave the moldy house, but then you need to get your body back to baseline through clean living. He warns against patients feeling that an additive supplement protocol is the answer; rather, it’s about removing the obstacles — poor food, toxins, stress — and letting the body’s intelligence take over. He quotes the concept of ‘pain to purpose to promise’ from PMPA, encouraging patients to use the experience as a catalyst for a healthier lifestyle. He observes that patients who adopt clean nutrition and lifestyle post-explant recover more thoroughly.

Dr. Brier explains that BII is a type of autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome), described by Shoenfeld and Talbert in 2011 and updated in 2023. The condition is characterized by a wide range of non-specific symptoms that develop insidiously, sometimes years after implantation. Unlike many autoimmune conditions, BII offers a unique therapeutic and diagnostic avenue: if symptoms improve or resolve after implant removal (de-challenge), the causal link is demonstrated. He stresses that it’s not that implants invariably cause illness — they act as an additional inflammatory driver in genetically or environmentally susceptible individuals, on top of other stressors like mold, biotoxins, or poor lifestyle. The lack of awareness among non-plastic-surgery physicians means patients often go through years of invalidation and unnecessary immunosuppressive medications before discovering BII through online communities or specialized surgeons.

Brier explains that he now informs every prospective implant patient about BII, and he believes that doing so is an ethical obligation. He doesn't advocate banning implants entirely — he supports patient autonomy — but insists that patients must know the potential long-term risks. He notes that the problem isn't only with plastic surgeons; the broader medical community (rheumatologists, endocrinologists, primary care) is not trained to consider BII when a patient with implants presents with non-specific inflammatory symptoms. By making BII part of standard informed consent, future patients would be able to advocate for themselves if they develop symptoms, and the medical system could appropriately attribute and address the issue, potentially saving years of invalidating dead ends.